Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young

MLA

Tomasz Klupa, et al. “Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young.” Diabetes Care, vol. 31, Aug. 2008, pp. 1496–501. EBSCOhost, https://doi.org/10.2337/dc07-2334.

APA

Tomasz Klupa, Jacek Sieradzki, Jan Skupien, Sylwia Górczyńska-Kosiorz, Krzysztof Wanic, Eric A. Button, & Maciej T. Malecki. (2008). Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young. Diabetes Care, 31, 1496–1501. https://doi.org/10.2337/dc07-2334

Chicago

Tomasz Klupa, Jacek Sieradzki, Jan Skupien, Sylwia Górczyńska-Kosiorz, Krzysztof Wanic, Eric A. Button, and Maciej T. Malecki. 2008. “Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young.” Diabetes Care 31 (August): 1496–1501. doi:10.2337/dc07-2334.